Outsourcing channel feed

Ready to ex­pand, Gen­Script rais­es $224M for CD­MO fo­cused on an­ti­bod­ies, cell and gene ther­a­pies

China’s GenScript has brought in new investors to back its biologics-focused subsidiary — to the tune of $224 million.

GenScript, which is listed in Hong Kong, disclosed the Series C for GenScript ProBio in a filing. The new funds will help “build up manufacturing capacity, further research and development capabilities and opportunistically acquire assets” to develop ProBio’s contract development and manufacturing business, the mother company wrote.